| No. |
Name
Length
|
Chromosome No./Scaffold Id
Scaffold Length |
BLAST (vs nr) |
Gene ontology |
| 4321 |
O_BomaMG16351_complete:A_BomaMG_comp25288_c2_seq1
599bp |
|
|
| GO:0000166 |
F |
nucleotide binding |
| GO:0000287 |
F |
magnesium ion binding |
| GO:0001816 |
P |
cytokine production |
| GO:0002376 |
P |
immune system process |
| GO:0002446 |
P |
neutrophil mediated immunity |
| GO:0004672 |
F |
protein kinase activity |
| GO:0004674 |
F |
protein serine/threonine kinase activity |
| GO:0005149 |
F |
interleukin-1 receptor binding |
| GO:0005515 |
F |
protein binding |
| GO:0005524 |
F |
ATP binding |
| GO:0005615 |
C |
extracellular space |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0007165 |
P |
signal transduction |
| GO:0007254 |
P |
JNK cascade |
| GO:0016301 |
F |
kinase activity |
| GO:0016310 |
P |
phosphorylation |
| GO:0016740 |
F |
transferase activity |
| GO:0019221 |
P |
cytokine-mediated signaling pathway |
| GO:0035556 |
P |
intracellular signal transduction |
| GO:0043123 |
P |
positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0045087 |
P |
innate immune response |
| GO:0048661 |
P |
positive regulation of smooth muscle cell proliferation |
| GO:1990266 |
P |
neutrophil migration |
|
| 4322 |
O_BomaMG16352_complete:A_BomaMG_comp25288_c4_seq1
352bp |
|
|
| GO:0005886 |
C |
plasma membrane |
| GO:0007275 |
P |
multicellular organism development |
| GO:0012506 |
C |
vesicle membrane |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016023 |
C |
cytoplasmic vesicle |
| GO:0016055 |
P |
Wnt signaling pathway |
| GO:0031410 |
C |
cytoplasmic vesicle |
|
| 4323 |
O_BomaMG16354_complete:A_BomaMG_comp25288_c5_seq1
181bp |
|
|
| GO:0000228 |
C |
nuclear chromosome |
| GO:0000977 |
F |
RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO:0003676 |
F |
nucleic acid binding |
| GO:0003677 |
F |
DNA binding |
| GO:0003700 |
F |
DNA-binding transcription factor activity |
| GO:0004803 |
F |
transposase activity |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0006357 |
P |
regulation of transcription by RNA polymerase II |
| GO:0015629 |
C |
actin cytoskeleton |
| GO:0046872 |
F |
metal ion binding |
| GO:0046983 |
F |
protein dimerization activity |
|
| 4324 |
O_BomaMG16356_3prime_partial:A_BomaMG_comp25289_c2_seq1
549bp |
|
|
| GO:0000166 |
F |
nucleotide binding |
| GO:0003676 |
F |
nucleic acid binding |
| GO:0003713 |
F |
transcription coactivator activity |
| GO:0003723 |
F |
RNA binding |
| GO:0004004 |
F |
RNA helicase activity |
| GO:0004386 |
F |
helicase activity |
| GO:0005515 |
F |
protein binding |
| GO:0005524 |
F |
ATP binding |
| GO:0005634 |
C |
nucleus |
| GO:0005654 |
C |
nucleoplasm |
| GO:0005730 |
C |
nucleolus |
| GO:0006351 |
P |
transcription, DNA-templated |
| GO:0006355 |
P |
regulation of transcription, DNA-templated |
| GO:0009791 |
P |
post-embryonic development |
| GO:0010501 |
P |
RNA secondary structure unwinding |
| GO:0016020 |
C |
membrane |
| GO:0016787 |
F |
hydrolase activity |
| GO:0030331 |
F |
estrogen receptor binding |
| GO:0033148 |
P |
positive regulation of intracellular estrogen receptor signaling pathway |
| GO:0044822 |
F |
RNA binding |
| GO:0045893 |
P |
positive regulation of transcription, DNA-templated |
| GO:0045944 |
P |
positive regulation of transcription by RNA polymerase II |
| GO:0072358 |
P |
circulatory system development |
| GO:2001014 |
P |
regulation of skeletal muscle cell differentiation |
|
| 4325 |
O_BomaMG16358_complete:A_BomaMG_comp25289_c2_seq2
463bp |
|
|
| GO:0000122 |
P |
negative regulation of transcription by RNA polymerase II |
| GO:0000166 |
F |
nucleotide binding |
| GO:0000381 |
P |
regulation of alternative mRNA splicing, via spliceosome |
| GO:0000398 |
P |
mRNA splicing, via spliceosome |
| GO:0003676 |
F |
nucleic acid binding |
| GO:0003712 |
F |
transcription coregulator activity |
| GO:0003713 |
F |
transcription coactivator activity |
| GO:0003723 |
F |
RNA binding |
| GO:0003724 |
F |
RNA helicase activity |
| GO:0004004 |
F |
RNA helicase activity |
| GO:0004386 |
F |
helicase activity |
| GO:0005515 |
F |
protein binding |
| GO:0005516 |
F |
calmodulin binding |
| GO:0005524 |
F |
ATP binding |
| GO:0005634 |
C |
nucleus |
| GO:0005654 |
C |
nucleoplasm |
| GO:0005681 |
C |
spliceosomal complex |
| GO:0005730 |
C |
nucleolus |
| GO:0006351 |
P |
transcription, DNA-templated |
| GO:0006355 |
P |
regulation of transcription, DNA-templated |
| GO:0006397 |
P |
mRNA processing |
| GO:0008380 |
P |
RNA splicing |
| GO:0009299 |
P |
mRNA transcription |
| GO:0010501 |
P |
RNA secondary structure unwinding |
| GO:0016020 |
C |
membrane |
| GO:0016049 |
P |
cell growth |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016818 |
F |
hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides |
| GO:0019899 |
F |
enzyme binding |
| GO:0030331 |
F |
estrogen receptor binding |
| GO:0030529 |
C |
ribonucleoprotein complex |
| GO:0033148 |
P |
positive regulation of intracellular estrogen receptor signaling pathway |
| GO:0036002 |
F |
pre-mRNA binding |
| GO:0043517 |
P |
positive regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0044822 |
F |
RNA binding |
| GO:0045069 |
P |
regulation of viral genome replication |
| GO:0045667 |
P |
regulation of osteoblast differentiation |
| GO:0045944 |
P |
positive regulation of transcription by RNA polymerase II |
| GO:0048306 |
F |
calcium-dependent protein binding |
| GO:0048511 |
P |
rhythmic process |
| GO:0050681 |
F |
androgen receptor binding |
| GO:0060765 |
P |
regulation of androgen receptor signaling pathway |
| GO:0070062 |
C |
extracellular exosome |
| GO:0071013 |
C |
catalytic step 2 spliceosome |
| GO:0072332 |
P |
intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:2001014 |
P |
regulation of skeletal muscle cell differentiation |
|
| 4326 |
O_BomaMG1635_3prime_partial:A_BomaMG_comp12635_c0_seq1
471bp |
|
PREDICTED:_peptidyl-prolyl_cis-trans_isomerase_CWC27_homolog_isoform_X1_[Bombyx_mori] |
| GO:0000398 |
P |
mRNA splicing, via spliceosome |
| GO:0000413 |
P |
protein peptidyl-prolyl isomerization |
| GO:0003755 |
F |
peptidyl-prolyl cis-trans isomerase activity |
| GO:0005634 |
C |
nucleus |
| GO:0006457 |
P |
protein folding |
| GO:0016853 |
F |
isomerase activity |
| GO:0071013 |
C |
catalytic step 2 spliceosome |
|
| 4327 |
O_BomaMG16360_complete:A_BomaMG_comp25290_c0_seq1
966bp |
|
|
| GO:0001664 |
F |
G protein-coupled receptor binding |
| GO:0002576 |
P |
platelet degranulation |
| GO:0005515 |
F |
protein binding |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0005737 |
C |
cytoplasm |
| GO:0005739 |
C |
mitochondrion |
| GO:0005764 |
C |
lysosome |
| GO:0005765 |
C |
lysosomal membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0006687 |
P |
glycosphingolipid metabolic process |
| GO:0006869 |
P |
lipid transport |
| GO:0007193 |
P |
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| GO:0008047 |
F |
enzyme activator activity |
| GO:0008289 |
F |
lipid binding |
| GO:0010506 |
P |
regulation of autophagy |
| GO:0016021 |
C |
integral component of membrane |
| GO:0019216 |
P |
regulation of lipid metabolic process |
| GO:0043085 |
P |
positive regulation of catalytic activity |
| GO:0043202 |
C |
lysosomal lumen |
| GO:0043408 |
P |
regulation of MAPK cascade |
| GO:0043410 |
P |
positive regulation of MAPK cascade |
| GO:0048589 |
P |
developmental growth |
| GO:0060736 |
P |
prostate gland growth |
| GO:0060742 |
P |
epithelial cell differentiation involved in prostate gland development |
| GO:0070062 |
C |
extracellular exosome |
| GO:0071310 |
P |
cellular response to organic substance |
| GO:1903206 |
P |
negative regulation of hydrogen peroxide-induced cell death |
|
| 4328 |
O_BomaMG16364_complete:A_BomaMG_comp25291_c0_seq1
342bp |
|
|
| GO:0001671 |
F |
ATPase activator activity |
| GO:0005515 |
F |
protein binding |
| GO:0005737 |
C |
cytoplasm |
| GO:0005783 |
C |
endoplasmic reticulum |
| GO:0005829 |
C |
cytosol |
| GO:0006950 |
P |
response to stress |
| GO:0032781 |
P |
positive regulation of ATP-dependent activity |
| GO:0051087 |
F |
chaperone binding |
| GO:0070062 |
C |
extracellular exosome |
|
| 4329 |
O_BomaMG16365_complete:A_BomaMG_comp25292_c0_seq1
206bp |
|
|
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0005886 |
C |
plasma membrane |
| GO:0006810 |
P |
transport |
| GO:0006869 |
P |
lipid transport |
| GO:0017089 |
F |
glycolipid transfer activity |
| GO:0046836 |
P |
glycolipid transport |
| GO:0051861 |
F |
glycolipid binding |
|
| 4330 |
O_BomaMG16366_complete:A_BomaMG_comp25292_c0_seq2
206bp |
|
|
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0005886 |
C |
plasma membrane |
| GO:0006810 |
P |
transport |
| GO:0006869 |
P |
lipid transport |
| GO:0017089 |
F |
glycolipid transfer activity |
| GO:0046836 |
P |
glycolipid transport |
| GO:0051861 |
F |
glycolipid binding |
|
| 4331 |
O_BomaMG16368_3prime_partial:A_BomaMG_comp25293_c0_seq1
404bp |
|
|
|
| 4332 |
O_BomaMG1636_3prime_partial:A_BomaMG_comp12635_c0_seq2
371bp |
|
PREDICTED:_peptidyl-prolyl_cis-trans_isomerase_CWC27_homolog_isoform_X1_[Bombyx_mori] |
| GO:0000413 |
P |
protein peptidyl-prolyl isomerization |
| GO:0003755 |
F |
peptidyl-prolyl cis-trans isomerase activity |
| GO:0006457 |
P |
protein folding |
| GO:0016853 |
F |
isomerase activity |
|
| 4333 |
O_BomaMG16370_complete:A_BomaMG_comp25293_c0_seq2
626bp |
|
|
|
| 4334 |
O_BomaMG16373_complete:A_BomaMG_comp25293_c0_seq3
651bp |
|
|
|
| 4335 |
O_BomaMG16374_complete:A_BomaMG_comp25293_c0_seq4
512bp |
|
|
|
| 4336 |
O_BomaMG16375_complete:A_BomaMG_comp25293_c0_seq4
405bp |
|
|
|
| 4337 |
O_BomaMG16377_complete:A_BomaMG_comp25293_c0_seq5
195bp |
|
|
|
| 4338 |
O_BomaMG16378_complete:A_BomaMG_comp25293_c0_seq5
150bp |
|
|
|
| 4339 |
O_BomaMG16379_complete:A_BomaMG_comp25293_c0_seq5
133bp |
|
|
|
| 4340 |
O_BomaMG16380_complete:A_BomaMG_comp25293_c0_seq6
264bp |
|
|
|
| 4341 |
O_BomaMG16382_complete:A_BomaMG_comp25293_c0_seq7
150bp |
|
|
|
| 4342 |
O_BomaMG16383_3prime_partial:A_BomaMG_comp25293_c0_seq7
149bp |
|
|
|
| 4343 |
O_BomaMG16385_complete:A_BomaMG_comp25293_c0_seq8
150bp |
|
|
|
| 4344 |
O_BomaMG16386_complete:A_BomaMG_comp25293_c0_seq9
379bp |
|
|
|
| 4345 |
O_BomaMG16387_3prime_partial:A_BomaMG_comp25293_c0_seq9
149bp |
|
|
|
| 4346 |
O_BomaMG16388_complete:A_BomaMG_comp25293_c0_seq10
741bp |
|
|
|
| 4347 |
O_BomaMG16389_complete:A_BomaMG_comp25293_c0_seq10
195bp |
|
|
|
| 4348 |
O_BomaMG1638_internal:A_BomaMG_comp12636_c0_seq1
224bp |
|
PREDICTED:_splicing_factor,_arginine/serine-rich_15_[Bombyx_mori] |
| GO:0003146 |
P |
heart jogging |
| GO:0003682 |
F |
chromatin binding |
| GO:0005634 |
C |
nucleus |
| GO:0006412 |
P |
translation |
| GO:0007049 |
P |
cell cycle |
| GO:0007064 |
P |
mitotic sister chromatid cohesion |
| GO:0007417 |
P |
central nervous system development |
| GO:0007507 |
P |
heart development |
| GO:0009303 |
P |
rRNA transcription |
| GO:0010468 |
P |
regulation of gene expression |
| GO:0035118 |
P |
embryonic pectoral fin morphogenesis |
| GO:0048565 |
P |
digestive tract development |
| GO:0048703 |
P |
embryonic viscerocranium morphogenesis |
| GO:0060828 |
P |
regulation of canonical Wnt signaling pathway |
| GO:0071733 |
P |
obsolete transcriptional activation by promoter-enhancer looping |
|
| 4349 |
O_BomaMG16391_complete:A_BomaMG_comp25293_c0_seq11
512bp |
|
|
|
| 4350 |
O_BomaMG16392_complete:A_BomaMG_comp25293_c0_seq11
195bp |
|
|
|
